Attachment A Purchased Material Quality Terms
Exhibit 10.20
STRATEGIC SUPPLIER ALLIANCE AGREEMENTCONTRACT MANUFACTURING GE HEALTHCARE
PARTIES
GE Healthcare entity (GEHC) GE Healthcare Bio-Sciences AB Address Björkgatan 30, 751 84 Uppsala, Sweden Registration number 556108-1919 | Other Party (the Supplier) Novozymes Biopharma Sweden AB Address St Lars väg 47, 220 09 Lund Registration number 556627-0830 | |
AGREEMENT |
GEHC REF: 132145 |
The Parties hereby agree that the following terms and conditions shall apply:
A. | Purpose |
GEHC and the Supplier are entering into this Agreement for the outsourcing by GEHC of the manufacture of the Products by the Supplier and thereby replacing the Contract Manufacturing and Purchasing Agreement, dated Sep 1 2005, between the Parties as specified below.
Pursuant to above prerequisites and the terms and condition of this Agreement, the Supplier shall manufacture and sell to GEHC, and GEHC shall purchase from the Supplier the Products, defined in Attachment C (the Products) in such amounts as GEHC may order from time to time on the terms and conditions set out in the Agreement. GEHC shall pay the price of the Products specified in Attachment C (the Prices). The Parties have agreed to jointly perform technology transfer projects (TT Programs) enabling the Supplier to manufacture Recombinant Products Zäta and rPA as set forth in Attachment L below.
The Parties agree that the scope of the contract manufacturing services performed hereunder (including packaging and quality control) will be specified by Production Documents as defined below.
Effective 12 December 2008 GEHC has granted Suppliers parent company a license to develop, manufacture, use, sell and have sold nPA (as defined herein), and hereunder to purchase chromatography media and receive working cell banks from GEHC for the practice of the license on the terms of the existing contract manufacturing agreement between GEHC and the Supplier. Said purchasing chromatography media and receiving working cell banks shall be governed by this Agreement, once effective.
B. | Documents |
The following attachments are an integral part of this Agreement (the Attachments). The provisions of each Attachment shall be incorporated by reference into and deemed to be part of this Agreement. The order of precedence shall be as follows, unless otherwise agreed:
QUALITY & INTEGRITY TERMS
Attachment A Supplier Quality Requirements
Attachment B Supplier Integrity Statement
BUSINESS TERMS
Attachment C Products, Prices, Specifications (if any),
Attachment D Business Terms
Attachment D Business Terms
Attachment I GEHC initial 24 months rolling forecast starting from effective date
Attachment J Media lead time schedule
GENERAL TERMS
Attachment E General Terms and Conditions
TECHNICAL TERMS
Attachment F GEHC Production know-how of the Recombinant Product
Attachment G GEHC Production know-how Native Products
Attachment H GEHC Production know-how Lego Products
Portions of this Exhibit were omitted and have been filed separately with the Secretary of the Commission pursuant to the Companys application requesting confidential treatment under Rule 24b-2 of the Exchange Act; [*] denotes omissions.
Attachment K Production Documents generated by the Supplier
Attachment L TT Programs
C. | Term |
Effective Date: The date of the last of the below signatures
Agreement Term: This Agreement shall commence on the Effective Date and, subject to the rights of termination in clause 16 of Attachment E, shall continue up to 31st of December 2016. The Parties shall negotiate eighteen (18) months prior to the expiration of the Term to decide whether to renew this Agreement.
This Agreement has been duly executed by each of the Parties
Signed for and on behalf of GEHC | Signed for and on behalf of the Supplier | |||||||
Date: June 30, 2011 | Date: 2011 07 07 | |||||||
Signature | /s/ Magnus Lundgren | Signature | /s/ Mikael Bundgaard-Nielsen | |||||
Name (capitals) | Magnus Lundgren | Name (capitals) | Mikael Bundgaard-Nielsen | |||||
Title | Global Sourcing Executive | Title | Vice President | |||||
Signed for and on behalf of the Supplier | ||||||||
Date: | ||||||||
Signature |
| |||||||
Name (capitals) |
|
Title |
|
Portions of this Exhibit were omitted and have been filed separately with the Secretary of the Commission pursuant to the Companys application requesting confidential treatment under Rule 24b-2 of the Exchange Act; [*] denotes omissions.
Attachment A
Purchased Material Quality Terms
SUPPLIER NAME:
Version No.:
The Parties are committed to quality in the performance of this Agreement. Accordingly, all Products shall conform to the Purchased Material Quality Requirements set forth below.
SECTION 1 QUALITY SYSTEMS: The Supplier shall maintain a documented quality system, and the Supplier shall be in compliance with ISO9001 or equivalent. Key components of a robust quality system are properly implemented quality procedures for collection and processing defects (parts or services), appropriate statistical techniques to analyze defects and identifying opportunities for corrective and preventive actions, along with evidence of validation that actions are effective in eliminating and preventing further defects. Upon request from GE Healthcare, the Supplier shall provide documented corrective action plans to prevent future deviations from the specification within thirty (30) days from receiving a corrective action request from GE Healthcare.
To ensure products and services provided to GEHC the Supplier shall meet or exceed GEHC requirements, GEHC may audit the Suppliers quality system at periodic intervals upon 30 days written advance notification, to inspect and observe the Suppliers manufacture of Products, to audit the Suppliers quality control and inspection procedures, and to have access to all data and documentation from such control of the Products and to receive samples and make such other investigations as GEHC deems necessary. The Supplier shall reserve the right for GEHC to perform such inspections on the premises of subcontractors engaged by the Supplier, such inspections to be scheduled by the Supplier following reasonable prior notice by GEHC and to be carried out jointly by representatives of both Parties and at the sole expense of GEHC. GEHCs right of inspection under this head shall not diminish the Suppliers obligation to deliver Products which comply with the specifications of this Agreement GEHC may also request periodic, joint quality assurance meetings at the Suppliers facility to discuss and resolve product quality and reliability issues.
SECTION 2 QUALITY RECORD RETENTION: If the Supplier is required to perform acceptance and release activities per GEHC written agreement or purchase specification, the Supplier shall maintain records of the acceptance and release activities for the services performed and/or products and services delivered to GEHC. These records may include as appropriate test/inspection criteria, revision level of documents/equipment/software used, operating procedures (planning, routing or traveler sheets), dates of test/inspection, and the results. The records required shall be retained at the Supplier and available for GEHC upon reasonable notice in advance, for at least ten (10) years from the date of manufacture and after 10 years retention at Supplier, the required records shall be submitted to GEHC with a written notice of 30 days, unless the Parties agree to extend the retention of the records at the Supplier or discord the record.
SECTION 3 COMPLIANCE: The Supplier shall comply with the terms of the Purchase Order or purchase agreement with GE Healthcare (Agreement). The Supplier shall maintain compliance with any and all laws and government regulations that apply in the manufacturing and delivery of its products or services. Such laws may include, but are not limited to, regulations and directives, labor laws, environmental laws, Custom Trade Partnership Against Terrorism (CTPAT) and product safety laws. The Supplier shall provide GE Healthcare all information requested that is necessary to enable GE Healthcare to comply with the laws and regulations applicable to the GE Healthcare sale and use of GE Healthcare products. As per GE Healthcare purchase specifications or for OEM (Original Equipment Manufacturer! items, the Supplier shall maintain compliance to industry standards and product listings for all Products delivered to GE Healthcare.
SECTION 4 CHANGE NOTIFICATION:
Product changes affecting specifications, quality, form, fit, function, regulatory compliance, etc. proposed by the Supplier are governed by Attachment E, Section 6.2 hereof Product changes affecting specifications, quality, form, fit, function, regulatory compliance, etc. proposed by GEHC are governed by the terms of Attachment E, Section 6.1 hereof.
Portions of this Exhibit were omitted and have been filed separately with the Secretary of the Commission pursuant to the Companys application requesting confidential treatment under Rule 24b-2 of the Exchange Act; [*] denotes omissions.
SECTION 5 SPECIFICATIONS: The Supplier is responsible to meet or exceed the part requirements and Specifications as referenced in the Agreement. The Supplier is accountable to ensure that delivered items meet the requirements of the revisions and/or versions specified on the applicable Agreement.
The Supplier shall ensure that GEHC documentation is controlled and distributed with the correct revision level to the appropriate personnel that produce the product for GEHC. The Supplier shall also ensure that all GEHC documentation is treated as proprietary and confidential, unless otherwise agreed.
For GEHC designed Products, the Supplier is responsible for ensuring that all applicable GEHC documentation is provided to all of the Suppliers Sub-Suppliers involved in the supply of product for GEHC. The Supplier shall ensure that both they and their Sub-Suppliers that use GEHC engineering documentation are maintained in compliance with all accepted Engineering Change Requests/Engineering Change Orders issued by GEHC.
Supplier shall be responsible for the qualification of all new equipment, computer systems and facilities associated with the manufacture, storage or testing of the Products as required.
SECTION 6 TRAINING:
Supplier shall ensure that all personnel performing the functions to support the critical systems outlined in this Agreement are trained according to Suppliers internal procedures and processes.
SECTION 7 SAMPLES
The Supplier shall retain sufficient samples from each of the Products to perform at least two (2) full retests of the agreed Specification for a period of one (1) year after the expiration of the Product Samples shall be stored at or lower than a temperature of minus 15°C and in standard containers. The Supplier shall advise GEHC before disposal of retained samples.
SECTION 8 PACKAGING AND SHIPPING METHODS: The Supplier shall provide packaging and shipping methods to prevent cosmetic and mechanical damage to the Product. The Supplier shall meet or exceed the detailed specifications of the GEHC packaging requirements found in the Specification
SECTION 9 ORDER OF PRECEDENCE: This attachment A shall be an addendum to the Strategic Supplier Alliance Agreement (SSAA) between Supplier and GEHC. Any conflict between this Attachment A and the other Attachments of the SSAA regarding the minimum material quality requirements shall be resolved pursuant to the terms of this Attachment A.
Portions of this Exhibit were omitted and have been filed separately with the Secretary of the Commission pursuant to the Companys application requesting confidential treatment under Rule 24b-2 of the Exchange Act; [*] denotes omissions.
By signing below, you agree to the terms hereof and consent to meet all requirements that apply for any and all products and services provided to GE Healthcare.
AGREED TO AND ACCEPTED BY SUPPLIER
SIGNATURE: | /s/ Mikael Bundgaard-Nielsen | |||
PRINTED NAME: | Mikael Bundgaard-Nielsen | |||
TITLE: | Vice President | |||
DATE: | 2011 07.07 | |||
SUPPLIER NAME | Novozymes Biopharma Sweden AB | |||
SIGNATURE: |
| |||
PRINTED NAME: |
| |||
TITLE: |
| |||
DATE: |
| |||
SUPPLIER NAME: |
|
AGREED TO AND ACCEPTED BY THE GENERAL ELECTRIC COMPANY ON BEHALF OF ITS DIVISION, GE HEALTHCARE
SIGNATURE: | /s/ Magnus Lundgren | |||
PRINTED NAME: | Magnus Lundgren | |||
TITLE: | Global Sourcing Executive | |||
DATE: | Jun 30, 2011 |
Portions of this Exhibit were omitted and have been filed separately with the Secretary of the Commission pursuant to the Companys application requesting confidential treatment under Rule 24b-2 of the Exchange Act; [*] denotes omissions.
Attachment B
Supplier Integrity Statement
Supplier Integrity, Business Conduct, and Compliance Requirements
A. | Supplier agrees (a) to have appropriate policies and governance in place and shall use its best efforts in order to comply with all applicable legal, as well as GEHC policy communicated to the Supplier requirements (including those relating to labor, the environment, health and safety, wages, hours and conditions of employment, occupational safety, discrimination, sexual harassment, immigration, minority owned businesses, intellectual property rights and improper payments); (b) that Supplier is responsible for ensuring that Suppliers employees, contractors, representatives and sub-suppliers understand and comply with the same legal and GEHC policy (as communicated to the Supplier) requirements; and (c) that the requirements referenced in (a) and (b) above include the following: |
(1) | Code of Conduct. Maintain and enforce written company policies requiring high ethical conduct and strict adherence to lawful business practices, including a prohibition against bribery of government officials. |
(2) | Labor Matters. |
(i) | Employ only workers above the applicable minimum age requirement or the age of 16 whichever is higher. |
(ii) | No use of forced, prison or indentured labor, workers subject to any form of compulsion or coercion, or labor in violation of minimum wage, hour of service, or overtime laws in the country of manufacture, and prohibit physical, sexual or psychological harassment or coercion. |
(iii) | Allow workers to freely choose whether to organize or join associations for the purpose of collective bargaining as provided by local law. |
(iv) | Assure that workers are hired, paid and otherwise subject to terms and conditions of employment based on their ability to do the job, not on the basis of their personal characteristics such as race, national origin, sex, religion, ethnicity, disability, maternity, age, and other characteristics protected by local law; provided, however, that the foregoing does not bar compliance with affirmative preferences that may be required by local law. |
(3) | Environmental Compliance. Comply with all applicable environmental laws and regulations, including: (i) maintaining and enforcing required environmental management programs; (ii) establish and maintain safeguards for the continuing compliance with all required environmental permits: and (iii) not permitting any discharge to the environment in violation of law, or that would otherwise have on adverse impact on the environment. |
(4) | Health & Safety. Provide workers with a safe workplace that complies with applicable health and safety standards as well as appropriate living conditions. |
(5) | Improper Payments and Business Dealings. Not offer or provide, directly or indirectly, anything of value (including cash, illegal political contributions, bribes or kickbacks or other improper payments) to any GEHC employee, representative, customer, government official, or other third party in connection with any GEHC procurement, transaction or business dealing. Prohibitions include offering or providing (directly or indirectly): (i) any consulting, employment or similar position to any GEHC employee (or their family member or significant other) involved with a GEHC procurement: (ii) GEHC employees and representatives with any gifts, other than gifts of nominal value to commemorate or recognize a particular GEHC-supplier business transaction or activity: and/or (iii) GEHC employees and/or representatives with the opportunity to participate in any contest, game or promotion. |
(6) | Business Entertainment of GEHC Employees and Representatives. Comply with the business entertainment (including travel and living] policies established and expressly communicated in writing by GEHC and which govern GEHC employees and representatives, including understanding those business entertainment policies of the applicable GEHC component or operation before offering or providing any GEHC employee or representative any form of business entertainment. Never offer to a GEHC employee or representative any form of business entertainment under circumstances that would create the appearance of on impropriety. |
(7) | Collusive Conduct and GEHC Procurements. Establish and maintain policies and safeguards and use best efforts to comply with all applicable competition laws, including, but not limited to: (i) not engage in prohibited communications or enter into agreements with competitors that con affect competition; (ii) not share or exchange any price, cost or other competitive information, nor engage in any other collusive conduct with any other third party supplier or bidder to GEHC with respect to any proposed, pending or current GEHC procurement: and (iii) avoid even the appearance of improper conduct. |
(8) | Intellectual & Other Property Rights. Respect the intellectual and other property rights of others, including GEHCs. Only use GEHC information and property (including tools, drawings and specifications! for the purpose for which they are expressly provided and for no other purposes. Take all reasonable steps to safeguard and maintain the confidentiality of GEHC proprietary information, including maintaining it in confidence, only in secure work areas, and not disclose it to any third parties without the prior written permission of GEHC. Observe and respect all GEHC patents, trademarks, trade secrets, and copyrights, as well as comply with such restrictions or prohibitions on their use as GEHC may from time to time establish. |
(9) | Export and International Trade Controls & Customs Matters. Establish and maintain policies and safeguards and use best efforts to comply with all applicable import and export control laws and regulations, including those of the United States, and not transfer GEHC technical information to any third party without the |
Portions of this Exhibit were omitted and have been filed separately with the Secretary of the Commission pursuant to the Companys application requesting confidential treatment under Rule 24b-2 of the Exchange Act; [*] denotes omissions.
express prior written permission of GEHC. Without limitation to the foregoing: (i) Establish and maintain policies and safeguards and use best efforts to comply with all applicable export controls laws and regulations in the export or re-export of GEHC technical information, including any restrictions on access and use applicable to non-U.S. nationals; and (iii ensure that all invoices and any customs or similar documentation submitted to GEHC or governmental authorities in connection with transactions involving GEHC accurately describe the goods and services provided or delivered and the price thereof. Supplier will also obtain all applicable permits and licenses necessary to perform its obligations under this Agreement, and upon GEHCs request, will provide GEHC with copies of such permits and licenses. Where Products contain United States components, Supplier will also provide GEHC with details of the United States content value as a percentage of the Product price upon GEHCs request. |
(10) | Privacy. With respect to data and personal information (including information of GEHC employees, its customers, suppliers, business partners, and patient health information handled and processed on behalf of its customers) (collectively, PI): (i) Establish and maintain policies and safeguards and use best efforts to comply with all applicable privacy and data protection laws globally, or generally acceptable privacy principles where comprehensive privacy laws are not available; (ii) Establish and maintain policies and safeguards and use best efforts to report any improper use or disclosure of PI, as well as successful security breaches, immediately upon becoming aware; (iii) Establish and maintain policies and safeguards and use best efforts to ensure that any employees, contractors, representatives and sub-suppliers to whom it provides PI and/or access to information systems, agree to the some restrictions and conditions set forth herein: (iv) facilitate audits by making its internal practices, books and records relating to the use and disclosure of PI available to GEHC and government agencies (including, the Secretary of the Department of Health and Human Services) for purposes of determining compliance with applicable laws, rules, and regulations; (v) when requested by GEHC, promptly return or destroy, as well as certify in writing to the return and destruction of, all PI and information in any form that allows access to GEHC information systems, and retain no copies of such PI and information: (vi) safeguard PI upon taking possession or exposure to employees and all third parties; and (vii) ensure that formal security management systems are employed that eliminates the risk of Pl-related security breaches; and (viii) notify GEHC in writing whenever PI will be exported from jurisdictions with data transfer restrictions, or transfer PI to countries without comprehensive data protections laws. |
(11) | Money Laundering Prevention. Comply with all applicable anti-money laundering laws and regulations and any reasonable GEHC policies established for money laundering prevention communicated expressly in writing. |
(12) | Prohibition of Use of Sub-Suppliers or Third Parties to Evade Requirements. Not use sub-suppliers or other third parties to illegally evade any applicable legal, including those enumerated above. |
(13) | Security Measures. Supplier warrants and represents that it will review and if relevant seek to reasonably adopt industry standard security measures which are consistent with accepted programs including the US Customs-Trade Partnership Against Terrorism (C-TPAT), the European Unions Authorized Economic Operator program and other similar programs where applicable |
(14) | Country of Origin. In accordance with and as required by applicable trade and customs laws. Supplier will mark each Product, as well as Product packaging, containers, labels, and invoices, with the country of origin for the Product. Supplier will also provide acceptable and auditable documentation that establishes the country of origin for all Products, including, without limitation and as applicable, certifications of origin for Products qualifying far EFTA/EU and other preferential duty provisions, as applicable. |
(15) | Policy Changes. GEHC policy requirements, including those enumerated above, are subject to modification by GEHC at any time. Such modifications shall only apply with regard the Supplier upon communication in writing and provided the Supplier does not object to such modification, which objection shall be mode in writing within 30 days from receipt of the communication. Supplier agrees to contact its GEHC representative if Supplier has any questions about the foregoing and/or their application to particular circumstances. |
B. | Products provided by Supplier may be subject to environmental, health and safety laws and regulations. As a result, Supplier agrees to the following without limitation: |
(1) | Supplier agrees to comply with all applicable national, EU, state/provincial and local labor, environmental, health and safety laws and regulations in connection with execution of this Agreement. |
(2) | Supplier will use all commercially reasonable efforts to establish and maintain an effective program to ensure that the activities of any suppliers it utilizes to provide any chemicals, substances, goods or services that will be incorporated into the Products supplied under this Agreement will be conducted in conformance with applicable law and regulation. |
AGREED TO AND ACCEPTED BY SUPPLIER
BY: | /s/ Mikael Bundgaard-Nielsen | BY: |
| |||||
TITLE: | Vice President | TITLE: |
| |||||
DATE: | 2011 07.07 | DATE: |
|
Portions of this Exhibit were omitted and have been filed separately with the Secretary of the Commission pursuant to the Companys application requesting confidential treatment under Rule 24b-2 of the Exchange Act; [*] denotes omissions.
SUPPLIER NAME: | Novozymes Biopharma Sweden AB |
Portions of this Exhibit were omitted and have been filed separately with the Secretary of the Commission pursuant to the Companys application requesting confidential treatment under Rule 24b-2 of the Exchange Act; [*] denotes omissions.
Attachment C
Products, Prices and Specifications
Currency: | SEK | |
Revision date: | April 4th 2011 |
The reference to Products shall include the two recombinant Products, 1) Zäta with the GEHC article number 28-4048-76 and 2) rPA with the GEHC article number 28-9932-16 (Recombinant Products) and the product, serum free Native Protein A, with the GEHC article number 30-6001-21 (Native Product) and the product Native Protein A (Lego Product). All three types of products; Recombinant Products, Native Product and Lego Product are covered by the term Product.
A. | RECOMBINANT PRODUCT: |
Product Name | Zäta | |
GEHC Article number | 28-4048-76 | |
Supplier Article Number | 6082-221 |
Unit size:
[*] Zäta per [*] meaning that the content per [*] shall be [*]. Each [*] shall be labeled with [*] Zäta. For remains achieved during filling the last [*] in each batch the actual quantity in [*] shall be stated on the label.
Price
SEK/[*] | [ | *] | [ | *] | [ | *] | [ | *] | [ | *] | [ | *] | ||||||||||||
Zäta ([*] [*]) | [ | *] | [ | *] | [ | *] | [ | *] | [ | *] | [ | *] | ||||||||||||
Zäta < [*] | [ | *] | [ | *] | [ | *] | [ | *] | [ | *] | [ | *] |
INCOTERMS: CIP GEHC Uppsala, but for any Purchase Order [*], the parties shall share equally the freight/insurance costs of such shipment subject to the transport invoice.
Lead time (PO):
[*]
Remaining shelf life upon delivery:
[*]
Level of Suppliers Safety Stock:
The safety stock will be [*] based on the average of the [*] of the at any time valid [*] rolling forecast distributed by GEHC and the [*] consumption by GEHC.
For the first year of Zäta supply, [*] safety stock level shall be based solely on the [*] rolling forecast.
Lead Times for Safety Stock Replenishment:
[*], the lead time for replenishment of purchased safety stock will be [*].
Shelf life
[*]
Portions of this Exhibit were omitted and have been filed separately with the Secretary of the Commission pursuant to the Companys application requesting confidential treatment under Rule 24b-2 of the Exchange Act; [*] denotes omissions.
B. | RECOMBINANT PRODUCT: |
Product Name | rPA | |
GEHC Article number | 28-9932-16 | |
Supplier Article Number | 6082-271 |
Unit size: [*] rPA per [*] meaning that the content per [*] shall be [*]. Each [*] shall be labeled with [*] rPA. For remains achieved during filling the last [*] in each batch the actual quantity in [*] shall be stated on the label.
Price:
SEK/[*] | [ | *] | [ | *] | [ | *] | [ | *] | [ | *] | [ | *] | ||||||||||||
Zäta ([*] [*]) | [ | *] | [ | *] | [ | *] | [ | *] | [ | *] | [ | *] | ||||||||||||
Zäta < [*] | [ | *] | [ | *] | [ | *] | [ | *] | [ | *] | [ | *] |
[*]
The above prices are based on the prerequisite that the total yield is around [*] starting from [*]. If the yield in the [*] is proven to be [*] higher or lower, the price shall be [*].
INCOTERMS: CIP GEHC Uppsala, but for any Purchase Order less than [*], the parties shall share equally the freight/insurance costs of such shipment subject to the transport invoice
Lead time IPO):
[*]
Remaining shelf life upon delivery:
[*]
Level of Suppliers Safety Stock:
The safety stock will be at least [*] based on the average of the [*] of the at any time valid [*] rolling forecast distributed by GEHC and [*] consumption by GEHC.
For the [*] rPA supply the [*] safety stock level shall be based solely on the [*] rolling forecast.
Shelf life:
[*]
Lead Times for Safety Stock Replenishment:
[*] the lead time for replenishment of purchased safety stock will be [*].
Portions of this Exhibit were omitted and have been filed separately with the Secretary of the Commission pursuant to the Companys application requesting confidential treatment under Rule 24b-2 of the Exchange Act; [*] denotes omissions.
C. | NATIVE PRODUCT: |
Product Name | Serum free Native Protein A (nPA) | |
GEHC Article number | 30-6001-21 | |
Supplier Article Number | 6082-220 |
Unit size: [*] nPA per [*] meaning that the content per [*] shall be [*]. Each [*] shall be labeled with [*] nPA. For remains achieved during filling the last [*] in each batch the actual quantity in [*] shall be stated on the label.
Price: The price on nPA will be [*].
INCOTERMS: CIP GEHC Uppsala, but for any Purchase Order less than [*], the parties shall share equally the freight/ insurance costs of such shipment subject to the transport invoice.
Lead time (PO)
[*]
Remaining shelf life upon delivery:
[*]
Level of Suppliers Safety Stock:
The safety stock will be [*] based on the average of the [*] of the at any time valid [*] rolling forecast distributed by GEHC and the [*] consumption by GEHC
For [*] the safety stock level shall be [*].
Shelf life
[*]
Lead Times for Safety Stock Replenishment:
[*], the lead time for replenishment of purchase safety stock will be [*].
Portions of this Exhibit were omitted and have been filed separately with the Secretary of the Commission pursuant to the Companys application requesting confidential treatment under Rule 24b-2 of the Exchange Act; [*] denotes omissions.
D. | LEGO PRODUCT: |
Product Name | Native Protein A (PA) | |
GEHC Article number | N/A | |
Supplier Article Number |
Specification: [*].
Price:
The price on PA will be [*]
INCOTERMS: CIP GEHC Uppsala, but for any Purchase Order less than [*], the parties shall share equally the freight/insurance costs of such shipment subject to the transport invoice.
Lead time (PO):
[*].
Remaining shelf life upon delivery:
[*]
Level of Suppliers Safety Stock:
[*]
Shelf life:
[*]
Lead Times for Safety Stock Replenishment:
[*]
Special Terms for Lego Product:
a) | Lego Product is delivered as an [*]. |
b) | Each Purchase Order shall be firm and binding for GEHC and be for [*] of Lego Product. |
c) | GEHC will provide the Supplier with [*]. |
***
Portions of this Exhibit were omitted and have been filed separately with the Secretary of the Commission pursuant to the Companys application requesting confidential treatment under Rule 24b-2 of the Exchange Act; [*] denotes omissions.
GENERAL PRICE TERMS:
Recombinant Products and Native Product:
All prices above are per gram and shall apply for deliveries made in the applicable calendar year.
[*].
In delivery documentation and invoices the stated quantity delivered shall be based on the unit size [*]. For remains achieved during filling the last [*] in each batch the actual quantity in [*] shall be stated on the label, in the delivery note and in the invoice.
Reference samples for the Recombinant Products and the Native Product, covering [*], to be provided to GEHC in the deliveries [*].
Gel Prices:
Throughout the period of the Agreement the below prices are [*].
Protein | Media | SEK/[*] | ||||||
ZätA* | [ | *] | [ | *] | ||||
[ | *] | [ | *] | |||||
[ | *] | [ | *] | |||||
nPA | [ | *] | [ | *] | ||||
[ | *] | [ | *] | |||||
rPA | [ | *] | [ | *] | ||||
[ | *] | [ | *] |
Additional charges: Unless otherwise agreed in this Agreement the Prices include all costs relating to the supply of the Products and GEHC shall not be obliged to reimburse the Supplier for any additional charges or any other costs relating to the supply of the Products that are not specified herein or otherwise agreed in writing by the Parties.
Portions of this Exhibit were omitted and have been filed separately with the Secretary of the Commission pursuant to the Companys application requesting confidential treatment under Rule 24b-2 of the Exchange Act; [*] denotes omissions.
Specifications
GE Healthcare
| ANALYTICAL SPECIFICATION RAW MATERIAL
30-6000-60 Ed. AH |
Issued by QA/ Johanna Ejdersund | Approved by R&D/ Philippe Busson | Established by QA/ Kjell Christensson | Valid from 2001-04-15 | Supersedes 30-6000-60 Ed. AG | PAGE 1(1) |
rProtein A
Code No: 30-600-60, 28-9932-16
1. Packaging instruction | The package shall be suitable for storage of the material. | |||||||||||||||||
2. Terms of transportation | At -18°C or below | |||||||||||||||||
3. Storage conditions | Preserve in a well-closed container at or below -18°C. | |||||||||||||||||
4. Remaining Shelf life | Shelf life is [*] from the date of manufacture. | |||||||||||||||||
5. Other name | rPa GE Healthcare | |||||||||||||||||
6. Formula and mass | Theoretical Mr: 34 318 Dalton calculated from amino acid sequence | |||||||||||||||||
7. Description | rProtein A is a recombinant engineered form of Staphylococcus aureus Protein A, produced by fermentation of Escherichia coli. The protein is produced with chemicals and materials of non-animal origin.
The product is supplied as a clear, amber frozen liquid free from particulates. |
8. Requirements on properties
Characteristic | Tolerance limit | Test method | Remark | |||
1. Visual examination | [*] | 45-2006-68 | ||||
2. IgG-binding activity, % | [*] | 04-0008-64 | ||||
3. Purity by size exclusion chromatography; % | [*] | 04-0008-66 | ||||
4. SDS-PAGE | [*] | 04-0008-65 | ||||
5. Protein concentration (A275): mg/ml) | [*] | 04-0048-69 | ||||
6. Microbial contamination, CFU/ml | [*] | 45-2006-39 | ||||
7. Endotoxin activity EU/mg rProtein A | [*] | 45-0306-72 |
GE and GE monogram are trademarks of General Electric Company.
©1999-2001 General Electric Company All rights reserved.
GE Healthcare Bio-Sciences AB, General Electric Company
Portions of this Exhibit were omitted and have been filed separately with the Secretary of the Commission pursuant to the Companys application requesting confidential treatment under Rule 24b-2 of the Exchange Act; [*] denotes omissions.
GE Healthcare
| ANALYTICAL SPECIFICATION RAW MATERIAL
30-6001-60 Ed. AH |
Issued by QA/ Johanna Ejdersund | Approved by R&D/ Herbert Baumann | Established by QA/ Christina Hult-Roos | Valid from 2010-04-29 | Supersedes 30-6001-09 Ed. AG | Page 1(1) |
nProtein A
Code No: 30-6001-09, -20, -21
1. Packaging instruction | The package shall be suitable for storage of the material. | |
2. Terms of transportation | At or below -18°C. | |
3. Storage conditions | Preserve in a well-closed container at or below -18°C. | |
4. Shelf life | Established shelf life is [*] from the date of manufacture. | |
5. Formula and mass | Theoretical Mr: 46 762 Dalton calculated from amino acid sequence | |
6. Description | Protein A is produced from a selected strain of Staphylococcus aureus Protein A. The protein binds to the Fc region of the immunoglobulin G and in some cases to immunoglobulin M and A. The substance is supplied as a clear yellowish or yellow-brown frozen liquid free from particles. The protein is produced with chemicals and materials of non-animal origin. |
7. Requirements on properties
Characteristic | Tolerance limit | Test method | Remark | |||
1. Visual examination | [*] | 45-2006-68 | ||||
2. IgG-binding activity, % | [*] | 04-0008-64 | ||||
3. Purity by size exclusion chromatography; % | [*] | 04-0008-66 | ||||
4. SDS-PAGE | [*] | 04-0008-65 | ||||
5. Protein conc (A275): mg/ml) | [*] | 45-2006-14 | ||||
6. Microbial contamination CFU/ml | [*] | 45-2006-39 | ||||
7. Endotoxin activity; EU/ml | [*] | 45-0306-72 | ||||
8. Content of endotoxin B µg/g protein A | [*] | 14-0015-63 |
GE and GE monogram are trademarks of General Electric Company.
©1999-2001 General Electric Company All rights reserved.
GE Healthcare Bio-Sciences AB, General Electric Company
Portions of this Exhibit were omitted and have been filed separately with the Secretary of the Commission pursuant to the Companys application requesting confidential treatment under Rule 24b-2 of the Exchange Act; [*] denotes omissions.
GE Healthcare
| ANALYTICAL SPECIFICATION RAW MATERIAL
14-0037-84 Ed. AD |
Issued by QA/ Elb-Jorde | Approved by R&D/ J Daicic | Valid from 2008-08-19 | Supersedes 14-0037-84 Ed. AB | Page 1(2) |
ZätA protein 905
Code No: 28-4048-76
1. Packaging instruction | The package shall be suitable for storage of the material. | |||||||
2. Terms of transportation | At or below -18°C. | |||||||
3. Storage conditions | Preserve in a well-closed container at or below -18°C. | |||||||
4. Shelf life | Established shelf life is [*] from the date of manufacture. Final shelf life is to be decided by stability studies. | |||||||
5. Formula and mass | Theoretical Mr: 26 748 Dalton calculated from amino acid sequence | |||||||
6. Description | ZätA protein is a recombinant protein produced by a Genetically Modified Organism (GMO) in a fermentation process. The substance is a clear, yellowish frozen liquid free from particulates, supplied in a buffer: 20 mM potassium phosphate 150 mM sodium chloride 2 mM EDTA pH 7.0 | |||||||
The bulk is to be manufactured according to our Base Method, number 14-0040-44. The protein is produced with chemicals and materials of non-animal origin. |
Portions of this Exhibit were omitted and have been filed separately with the Secretary of the Commission pursuant to the Companys application requesting confidential treatment under Rule 24b-2 of the Exchange Act; [*] denotes omissions.
GE Healthcare
| ANALYTICAL SPECIFICATION RAW MATERIAL
14-0037-84 Ed. AD |
Page 2(2) |
7. Requirements on properties
Characteristic | Tolerance limit | Test method | Remark | |||
1. Visual examination | [*] | 45-2006-68 | ||||
2. IgG-binding activity, % | [*] | 04-0008-64 | ||||
3. Purity by size exclusion chromatography; % | [*] | 04-0008-66 | ||||
4. SDS-PAGE | [*] | 04-0008-65 | ||||
5. Quantification; mg/ml | [*] | 04-0013-21 | ||||
6. Microbial contamination CFU/ml | [*] | 45-2006-39 Ed. AB | ||||
7. Endotoxin activity EU/mg ZätA protein | [*] | 45-0306-72 Ed. AF |
Comment:
GE and GE monogram are trademarks of General Electric Company.
©1999-2001 General Electric Company All rights reserved.
GE Healthcare Bio-Sciences AB, General Electric Company
Portions of this Exhibit were omitted and have been filed separately with the Secretary of the Commission pursuant to the Companys application requesting confidential treatment under Rule 24b-2 of the Exchange Act; [*] denotes omissions.
Attachment D
Business Terms
1. | Specifications |
The Products to be supplied in accordance with the terms of this Agreement are set forth in Products and Prices, Attachment C. A technical specification in relation to a specific Product is referred to as the Specification as set forth in Attachment C.
2. | Delivery documentation |
With each shipment the Supplier shall deliver the following documents to GEHC: Certificate of Analysis, Packing slip and the Commercial Invoice.
3. | Prices and Payment Terms |
a. | Firm Prices. The Prices of the Products are firm for the Term of this Agreement. Prices are quoted excl. VAT and other taxes. |
b. | Taxes. Unless prohibited by law, the Supplier will separately indicate on its Invoice any tax that is required to be imposed on the sale of Products. |
c. | Payment Terms. GEHC shall settle any undisputed invoices arising under this Agreement [*] ([*]) days after receiving on Invoice prepared in accordance with the terms of this Agreement. Invoices shall be issued upon delivery. All sums to be paid by GEHC under this Agreement shall be in the currency specified in Attachment C. Interest for late payments shall not apply to payments that GEHC contests in good faith and shall in no event exceed applicable statutory interest rate. |
d. | [*]. |
e. | Invoicing requirements. The Suppliers Invoices shall contain the GEHC Purchase Order number and other such information as may be required by law or requested from time to time by GEHC. Each cost item shall be specified in the invoice. The stated and delivered quantities shall match between the invoice, actual delivery and in the delivery documentation, based on the use of the unit size as specified in Attachment C. Invoices shall be addressed to GEHC or the GEHC affiliate who has placed the purchase order with the Supplier. |
f. | [*] |
Portions of this Exhibit were omitted and have been filed separately with the Secretary of the Commission pursuant to the Companys application requesting confidential treatment under Rule 24b-2 of the Exchange Act; [*] denotes omissions.
4. | Components and Materials |
At GEHCs option, GEHC may instruct the Supplier to procure or provide all materials and components necessary for the manufacture of the Products from on approved supplier, in which case an approved suppliers list shall be maintained by the Supplier. Any new suppliers selected by the Supplier in connection with the Agreement must be approved by GEHC, whereupon they may be added to such approved suppliers list. Any verified change of cost of raw materials resulting from GEHCs instruction to change supplier, shall effect the price of the concerned Product in the same proportion as the change of the Suppliers production cost of the concerned Product.
5. | Additional Suppliers |
The Supplier shall, at GEHCs written request, provide reasonable assistance to GEHC with regard to GEHCs efforts to have back-up manufacturing solutions in place for the Products (i) by providing GEHC or such designee with copies of all written embodiments of Production Document (ii) by making relevant personnel available within reason for consultation. Supplier may charge GEHC a reasonable fee for such services which shall be subject to agreement prior to initiation.
6. | Forecast and Commitment |
a. | Forecasting. [*] ([*]) days before the end of each quarter, GEHC shall submit to the Supplier in writing a [*] month rolling forecast (Forecast) broken down by Product ([*]) and into calendar quarters. Supplier shall use the Forecast as the basis for its production planning and shall adjust the Safety Stock according to the new Forecast within the agreed lead times. The Forecast shall reflect GEHCs best estimate of its need for the Products from the Supplier at the time of the submission, subject to section e) below. If GEHC is unable to provide a timely forecast, GEHC shall upon request be granted an extension of [*] ([*])days from the original Forecast due date. If the Forecast is not submitted at such time then the second quarter from the previous Forecast will be firm and binding on GEHC and the Supplier. |
b. | The Forecast. The [*] of every rolling Forecast provided by GEHC for the Recombinant Product and for the Native Product shall be [*] on GEHC and the Supplier. [*]. Upon receipt of the Forecast, Supplier shall notify GEHC if Supplier is unable to deliver according to said Forecast (including any specific quarter) included in the forecast. Supplier agrees to provide such notification to GEHC within [*] days. |
c. | General Supply Commitment. The Supplier shall use its best commercial efforts to manufacture and deliver the Recombinant Product and the Native Product within [*]. To ensure this is upheld, the Forecast will be assessed as described in section 14. In the event that the market demand exceeds this volume, GEHC and Supplier will work together and make best efforts to meet the market demand. If the Supplier should be unable to meet GEHCs requirements in accordance with the forecast or should fail to accept any orders in excess of the forecast within agreed time limits, the Parties agree GEHC shall be released from such part of its purchase commitment that the Supplier is unable to deliver on the requested delivery times |
d. | Purchase Commitment Recombinant Product. As a result of this Agreement, the Supplier will become a preferred supplier of GEHC for the Recombinant Products. The Parties have agreed that the annual deliveries shall be at least [*] ([*]) percent of GEHCs total actual requirements in [*] for the Recombinant Products. For the avoidance of doubt, the annual deliveries of individual Recombinant Products shall not be lower than [*]% of the total annual requirement for any particular Recombinant Product. |
The purchase commitment for a Recombinant Product shall start and be calculated at such time the following criteria for the Recombinant Product are met as part of the TT Programs:
a) | [*]; |
b) | [*] |
c) | [*], |
d) | [*] |
In the event GEHC should fail to fulfill its purchase obligations hereunder it shall immediately notify Supplier of such failure and as its sole liability immediately issue a purchase order for the missing
Portions of this Exhibit were omitted and have been filed separately with the Secretary of the Commission pursuant to the Companys application requesting confidential treatment under Rule 24b-2 of the Exchange Act; [*] denotes omissions.
quantities upon the Suppliers written request thereto. The Supplier agrees to maintain the equivalent ability to manufacture the Recombinant Product for GEHC.
If the Supplier during a certain [*] is unable to timely supply the Recombinant Product in quantities specified in GEHCs Forecast, then GEHCs purchasing commitment for that quarter shall be reduced with a quantity corresponding to the shortfall.
e. | Purchase commitment Native Product. As a result of this Agreement the Supplier will continue to be the supplier of GEHC for the Native Product. The Parties have agreed that the annual deliveries shall be no less than [*]% of GEHCs total actual requirements in [*] for the Native Product. GEHC reserves the right to develop alternative sources for the Native Product. In the event that such a project is started GEHC agrees to provide the Supplier with at least [*] months notice prior to the commencement of deliveries from an alternative supplier. In such an event the Parties agree to negotiate in good faith acceptable commercial and project management terms. |
f. | No further Obligation. Other than as set out in this Section 6, it is the express understanding of the Parties that GEHC shall have no further obligation to purchase Products exclusively from the Supplier or to purchase any further minimum amount of Products, and may use other suppliers for any and all Products, or similar products in accordance with the stipulated terms herein. |
7. | Contract Managers and Communication |
a. | Contract Manager. Both the Supplier and GEHC will appoint a contract manager to manage their respective obligations under this Agreement, to act as focal points between the two organizations and review progress on a quarterly basis. The contract manager shall be as specified below or such other person as subsequently communicated to the other Party. |
GEHC: [*]
Supplier: [*]
b. | Legal Notices (as set forth in Section 18 in Attachment E). |
GEHC: | Björkgatan 3 751 84 Uppsala, Sweden Fax No. [*] | |
Supplier: | St Lars väg 47, 220 09 Lund Fax No: |
c. | Crisis Communication. The Supplier must maintain the ability to contact or receive contact from GEHC on a twenty-four (24) hour per day, seven (7) days per week basis in order to communicate and manage crisis situations that threaten to or interrupt the supply chain. |
8. | Insurance |
During the term of this Agreement and for [*] thereafter each party undertakes to maintain a comprehensive liability insurance policy, products liability inclusive, at terms and conditions customary to the business. Such insurance shall be for on insured sum of not less than [*] Swedish kroner ([*] SEK) (or the equivalent in USD). Each party shall upon request furnish to the other party a certificate evidencing such insurance.
Portions of this Exhibit were omitted and have been filed separately with the Secretary of the Commission pursuant to the Companys application requesting confidential treatment under Rule 24b-2 of the Exchange Act; [*] denotes omissions.
9. | Safety Stock |
The Supplier shall keep a Safety Stock at the Suppliers premises, corresponding to the minimum set inventory values and the replenishment times in Attachment C.
The inventory levels stated in Attachment C shall be based on the latest [*] Forecast distributed by GEHC. In case a new Forecast leads to replenishment actions for the safety stock the Supplier shall use all commercially reasonable efforts to replenish the Safety Stock as soon as practical and always within the agreed lead times set forth in Attachment C.
The Supplier shall provide GEHC with finished goods inventory levels and Safety Stock levels within [*] days upon request from GEHC
10. | Manufacturing Process |
All written manufacturing or production documentation and records relating to the Products are defined as Production Document(s)
For avoidance of doubt the know how listed in attachments F, G, H and K and the know-how to be generated as part of the TT Programs, are deemed to be Production Documents and shall be the sole property of GEHC and may be only used for the purpose of manufacturing the Products on behalf of GEHC under this Agreement unless otherwise agreed in writing by the Parties. The Supplier shall document and GEHC shall have access to review all required written manufacturing or production records relating to any of the Products and upon request from GEHC, the Supplier is obliged to send GEHC copies of the requested Production Documents
The Supplier shall always keep and maintain the master list of Production Documents generated by the Supplier, initially stated in Attachment K, and the Supplier shall send upon GEHCs request on update of any of the documents included in the master list of Production Documents.
The approved validation reports for the completion of the tech transfer under the TT programs will act as baseline documents, over the production process for each of the Recombinant Products showing the starting fermentation volume, the yields for each of the process steps and the expected outcome per purification batch, to be used for example as a base in productivity improvement issues.
11. | Business interruption |
The Supplier undertakes to keep GEHC informed about any circumstances that might reasonably impact on the Suppliers ability to supply the Products, timely and in accordance with applicable quality standards, including any plans to close or divest the business relating to all or any of the Products. If such circumstance should arise or may reasonably be possible to arise the Supplier shall immediately inform GEHC and propose a plan on how to mitigate the consequences thereof. The Parties shall then in good faith conduct negotiations concerning the actions to be taken and the costs to avoid or mitigate the risks.
12. | Reports |
Reports:
GEHC will provide Supplier within [*] of the close of each [*] period a report of the total quantity of the Recombinant Products purchased by GEHC from all suppliers during the period.
13. | Performance goals |
The purpose of the performance goals are primarily for the Supplier to plan the operations at the Suppliers site and take preventive initiatives so that the set performance goals con be achieved. The results of the Suppliers performance in below areas should be a port of the business reviews between the two Parties. While the performance goals are targets and non-achievement of such goals shall not be considered as material breach of contract the Supplier agrees to use all commercially reasonable efforts to achieve the performance goals.
Performance goals as per GEHC:
Portions of this Exhibit were omitted and have been filed separately with the Secretary of the Commission pursuant to the Companys application requesting confidential treatment under Rule 24b-2 of the Exchange Act; [*] denotes omissions.
1. Deliveries within Specification, agreed lead times and quantities; performance goal is [*] according to the terms in Attachment C
2. Number of complaint reports sent to the Supplier by GEHC; performance goal is [*]
3. Business contingency plan audits and GEHC quality audits performed and with the result approved; performance goal is [*]
14. | Business reviews. |
The Parties shall preferably meet face to face and perform quality business reviews [*] with focus on quality, delivery, joint cost savings projects, change requests, forecasts.
The agenda for the [*] business review meetings should cover:
i. | Performance goals as per GEHC |
ii. | Forecast/Commitment |
iii. | Purchase commitment, both Parties |
iv. | Status on change requests and joint savings projects |
v. | Any other businesses |
15. | Audit |
Supplier shall have the right to have an independent third party reasonably acceptable to GEHC, such as one of the global auditing firms, to conduct an annual audit of GEHCs records to ensure compliance with GEHCs commitments according to Section 6d (minimum purchase) in said Section of the Agreement.
16. | Supply of GEHC products for the manufacture of Products |
During the term of this agreement the Supplier shall have the right to purchase the following products from GEHC at prices stipulated in Attachment C:
Name | Article No: | |
[*] |
Delivery conditions: CIP Lead time: Delivery lead times if Purchase Orders are placed in accordance to lead time schedule in Attachment J
Credit term: [*] days from date of invoice
Order handling: all order shall be submitted to [*] and copy to the Contract Managers, together with a declaration of the intended use for the Products.
The sale of the goods to the Supplier shall be subject to GEHC Conditions of Sale and the terms herein.
The products ordered in accordance with this Section may only be used in the manufacture of the Products for delivery to GEHC or products produced by Supplier under license to third party.
17. | Cell banks |
The biological starting material used in the fermentation process originates from the cell banks are kept and owned by GEHC. Such material may only be used in connection with the manufacture of the Products and shall be returned to GEHC, alternatively destroyed upon termination of this agreement for whatever reason, unless otherwise agreed by the parties in writing. Supplier shall not disclose or provide such material to any third parties, unless GEHC has given its prior written consent thereto. The Supplier agrees not to sequence, extract or in any other way use the plasmid, the chromosome or any of the DNA codes present in the cell banks.
Portions of this Exhibit were omitted and have been filed separately with the Secretary of the Commission pursuant to the Companys application requesting confidential treatment under Rule 24b-2 of the Exchange Act; [*] denotes omissions.
The Supplier may order starting material at no cost of Supplier according to the following conditions:
a) | Lead time: [*] days, unless otherwise agreed. |
b) | Orders: written orders in accordance with form provided by GEHC specifying product, campaign, numbers of vials and requested delivery date. The order will be sent to: |
GE Healthcare Bio-Sciences AB
Att: [*]
BL3-2
Björkgatan 30
751 84 UPPSALA
Sweden
tel: [*]
fax: [*]
c) | GEHC will confirm order without delay and provide a notice two weeks before the estimated delivery date. |
d) | Supplier shall confirm receipt of the cell bank. |
e) | Transportation: GEHC will coordinate with the Supplier to ensure appropriate delivery time and arrangements for the cell banks and will arrange and pay for transportation. |
Documentation: The cell banks will be accompanied by a Certificate of Analysis in accordance with the documents listed in Attachment F.
f) | The Supplier shall provide GEHC at the beginning of every [*] a report of the total quantity of seed stock for each of the Products as well as the planned consumption of the seed stock for the following [*] ([*]) months. GEHC shall use this information for their internal planning purposes. |
Portions of this Exhibit were omitted and have been filed separately with the Secretary of the Commission pursuant to the Companys application requesting confidential treatment under Rule 24b-2 of the Exchange Act; [*] denotes omissions.
Attachment E General Terms and Conditions
Portions of this Exhibit were omitted and have been filed separately with the Secretary of the Commission pursuant to the Companys application requesting confidential treatment under Rule 24b-2 of the Exchange Act; [*] denotes omissions.
Portions of this Exhibit were omitted and have been filed separately with the Secretary of the Commission pursuant to the Companys application requesting confidential treatment under Rule 24b-2 of the Exchange Act; [*] denotes omissions.
Portions of this Exhibit were omitted and have been filed separately with the Secretary of the Commission pursuant to the Companys application requesting confidential treatment under Rule 24b-2 of the Exchange Act; [*] denotes omissions.
Portions of this Exhibit were omitted and have been filed separately with the Secretary of the Commission pursuant to the Companys application requesting confidential treatment under Rule 24b-2 of the Exchange Act; [*] denotes omissions.
Portions of this Exhibit were omitted and have been filed separately with the Secretary of the Commission pursuant to the Companys application requesting confidential treatment under Rule 24b-2 of the Exchange Act; [*] denotes omissions.
Portions of this Exhibit were omitted and have been filed separately with the Secretary of the Commission pursuant to the Companys application requesting confidential treatment under Rule 24b-2 of the Exchange Act; [*] denotes omissions.
Portions of this Exhibit were omitted and have been filed separately with the Secretary of the Commission pursuant to the Companys application requesting confidential treatment under Rule 24b-2 of the Exchange Act; [*] denotes omissions.
Portions of this Exhibit were omitted and have been filed separately with the Secretary of the Commission pursuant to the Companys application requesting confidential treatment under Rule 24b-2 of the Exchange Act; [*] denotes omissions.
Portions of this Exhibit were omitted and have been filed separately with the Secretary of the Commission pursuant to the Companys application requesting confidential treatment under Rule 24b-2 of the Exchange Act; [*] denotes omissions.
Attachment F
GE Technology
Production know-how covering [*] with regard to rPA and ZätA protein, in particular as described in the following documentation.
Documentation title | GEHC Doc No. (when applicable) | |
rPA | ||
[*] | ||
ZätA | ||
[*] |
For avoidance of doubt, the above is not an exhaustive list of GE Technology, but describes certain key elements of the manufacturing process and test methods relating to the Products.
Portions of this Exhibit were omitted and have been filed separately with the Secretary of the Commission pursuant to the Companys application requesting confidential treatment under Rule 24b-2 of the Exchange Act; [*] denotes omissions.
Attachment G.
GE Technology
Production know-how covering [*] with regard to Native Product, in particular as described in the following documentation.
Documentation title | Doc No | |||
[*] | · |
For avoidance of doubt, the above is not an exhaustive list of GE Technology, but describes certain key elements of the manufacturing process and test methods relating to the Products.
Portions of this Exhibit were omitted and have been filed separately with the Secretary of the Commission pursuant to the Companys application requesting confidential treatment under Rule 24b-2 of the Exchange Act; [*] denotes omissions.
Attachment H.
GE Technology
Production know-how covering [*] with regard to Lego Product, in particular as described in the following documentation.
Documentation title | Doc No | |||
[*] |
For avoidance of doubt, the above is not an exhaustive list of GE Technology, but describes certain key elements of the manufacturing process and test methods relating to the Products.
Portions of this Exhibit were omitted and have been filed separately with the Secretary of the Commission pursuant to the Companys application requesting confidential treatment under Rule 24b-2 of the Exchange Act; [*] denotes omissions.
Attachment I
GEHC initial [*] rolling forecast starting from effective date
[ | *] | [ | *] | [ | *] | [ | *] | [ | *] | [ | *] | [ | *] | [ | *] | |||||||||||||||||
Zäta ([*]) | [ | *] | [ | *] | [ | *] | [ | *] | [ | *] | [ | *] | [ | *] | [ | *] | ||||||||||||||||
nPA ([*]) | [ | *] | [ | *] | [ | *] | [ | *] | [ | *] | [ | *] | [ | *] | [ | *] | ||||||||||||||||
rPA ([*]) | [ | *] | [ | *] | [ | *] | [ | *] | [ | *] | [ | *] | [ | *] | [ | *] |
Portions of this Exhibit were omitted and have been filed separately with the Secretary of the Commission pursuant to the Companys application requesting confidential treatment under Rule 24b-2 of the Exchange Act; [*] denotes omissions.
Attachment J
Lead time schedule
[*]
Portions of this Exhibit were omitted and have been filed separately with the Secretary of the Commission pursuant to the Companys application requesting confidential treatment under Rule 24b-2 of the Exchange Act; [*] denotes omissions.
Attachment K: Production Documents generated by the Supplier
The below listed documents represent the top documents in hierarchical document structure and will thus in itself reference to all relevant documents for the Suppliers production of the respective Products.
The specific documents are:
NZ Doc No | Title | |
[*] |
Portions of this Exhibit were omitted and have been filed separately with the Secretary of the Commission pursuant to the Companys application requesting confidential treatment under Rule 24b-2 of the Exchange Act; [*] denotes omissions.
Attachment L: TT Programs
A. | rPA |
1. | The Parties shall use their respective best efforts to complete the TT Programs without undue delay. The aim with the TT Programs is to transfer GEHCs manufacturing know-how needed to manufacture the rPA. |
2. | The TT Programs consists of the following main activities: |
1. | Transfer of analytical and production methods |
2. | Implementation, including validation of equipment and raw materials |
3. | Validation of process and finished product |
4. | Customer approval |
On the effective date of this Agreement points 1. and 2. above have been completed, and points 3. and 4. are pending.
3. | Each party will bear its own costs as a general principle. GEHC will pay for any productive material (material validated for use in GEHC production of final products) according to the agreed prices herein. |
4. | In case the process does not perform as expected the parties shall in good faith negotiate the cost for the further development needed. |
5. | GEHC shall supply Supplier with full documentation of the process and analytical methods including existing validation reports, provided GEHC is allowed to disclose such documentation considering any third party confidentiality obligations. |
6. | Approved product from the validation batches performed at Supplier shall be bought by GEHC according to the terms and conditions of this Agreement. |
B. | Zäta |
1. | The Parties shall use their respective best efforts to complete the TT Programs without undue delay. The aim with the TT Programs is to transfer GEHCs manufacturing know-how needed to manufacture the Zäta. |
2. | The TT Programs consists of the following main activities: |
1. | Transfer of analytical and production methods |
2. | Implementation including validation of equipment and raw materials |
3. | Validation of process and finished product |
Portions of this Exhibit were omitted and have been filed separately with the Secretary of the Commission pursuant to the Companys application requesting confidential treatment under Rule 24b-2 of the Exchange Act; [*] denotes omissions.
4. | Customer approval |
On the effective date of this Agreement points 1. to 3. have been completed, and point 4. is pending.
3. | Each party will bear its own costs as a general principle. GEHC will pay for any productive material (material validated for use in GEHC production of final products) according to agreed prices herein. |
4. | In case the process does not perform as expected the parties shall in good faith negotiate the cost for the development needed. |
5. | GEHC shall supply Supplier with full documentation of the process and analytical methods including existing validation reports, provided GEHC is allowed to disclose such documentation considering any third party confidentiality obligations. |
6. | Approved product from the validation batches performed at Supplier shall be bought by GEHC according to the terms and conditions of this agreement. |
Portions of this Exhibit were omitted and have been filed separately with the Secretary of the Commission pursuant to the Companys application requesting confidential treatment under Rule 24b-2 of the Exchange Act; [*] denotes omissions.